We are live on ! Find out more
RNVA

Rennova Health, Inc.
RNVA

Delisted

RNVA was delisted on the 24th of October, 2017.

5 hedge funds and large institutions have $100K invested in Rennova Health, Inc. in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding

Funds holding: 25 (+3)

6% less capital invested

Capital invested by funds: $106K → $100K (-$6K)

Holders
5
Holders Change
+3
Holders Change %
+150%
% of All Funds
0.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$2K

RNVA Hedge Fund Activity: Q3 2014 in Review

5 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Rennova Health, Inc. (RNVA) for Q3 2014, worth a combined $100K — down 5.7% from $106K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new RNVA positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $27.2K. The largest seller was Tower Research Capital (TRC), cutting an estimated $2K.

  • 5 institutional investors held Rennova Health, Inc. (RNVA) as of Q3 2014, up from 2 in Q2 2014.
  • Funds reported $100K of Rennova Health, Inc. stock for Q3 2014, down 5.7% quarter-over-quarter.
  • 3 funds opened new Rennova Health, Inc. positions in Q3 2014 and 0 closed out, a net change of +3 holders.
  • The largest Rennova Health, Inc. buyer in Q3 2014 was Citadel Advisors, an estimated $27.2K added.
  • The largest Rennova Health, Inc. seller in Q3 2014 was Tower Research Capital (TRC), an estimated $2K sold.

Based on aggregated 13F filings for Q3 2014.